9 research outputs found
3-PHENACYLURIDINE-DERIVED HYPNOTICS: ANTHOLOGY, STRUCTUREACTIVITY RELATIONSHIPS AND SYNTHESIS OF SEVERAL ACYCLONUCLEOSIDE ANALOGUES
This work was supported by the Russian Foundation for Basic Research, project # 18-33-00421
Diarylpyrimidine-Dihydrobenzyloxopyrimidine Hybrids: New, Wide-Spectrum Anti-HIV-1 Agents Active at (Sub)-Nanomolar Level.
Here, we describe a novel small series of nonnucleoside
reverse transcriptase inhibitors (NNRTIs) that combine
peculiar structural features of diarylpyrimidines (DAPYs)
and dihydro-alkoxy-benzyl-oxopyrimidines (DABOs). These
DAPYDABO hybrids (14) showed a characteristic SAR
profile and a nanomolar anti-HIV-1 activity at both enzymatic
and cellular level. In particular, the two compounds 4d and 2d,
with a (sub)nanomolar activity against wild-type and clinically
relevant HIV-1 mutant strains, were selected as lead compounds
for next optimization studies
2-(Alkyl/aryl)amino-6-benzylpyrimidin-4(3H)-ones as inhibitors of wild-type and mutant HIV-1: enantioselectivity studies.
The single enantiomers of two pyrimidine-based HIV-1 non-nucleoside reverse transcriptase inhibitors, 1 (MC1501) and 2 (MC2082), were tested in both cellular and enzyme assays. In general, the R forms were more potent than their S counterparts and racemates and (R)-2 was more efficient than (R)-1 and the reference compounds, with some exceptions. Interestingly, (R)-2 displayed a faster binding to K103N RT with respect to WT RT, while (R)-1 showed the opposite behavior. © 2012 American Chemical Societ
Structure-Based Design, Synthesis, and Biological Evaluation of the Cage–Amide Derived Orthopox Virus Replication Inhibitors
Despite the fact that the variola virus is considered eradicated, the search for new small molecules with activity against orthopoxviruses remains an important task, especially in the context of recent outbreaks of monkeypox. As a result of this work, a number of amides of benzoic acids containing an adamantane fragment were obtained. Most of the compounds demonstrated activity against vaccinia virus, with a selectivity index SI = 18,214 for the leader compound 18a. The obtained derivatives also demonstrated activity against murine pox (250 ≤ SI ≤ 6071) and cowpox (125 ≤ SI ≤ 3036). A correlation was obtained between the IC50 meanings and the binding energy to the assumed biological target, the p37 viral protein with R2 = 0.60